181 related articles for article (PubMed ID: 23864999)
1. Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke.
Mdzinarishvili A; Sutariya V; Talasila PK; Geldenhuys WJ; Sadana P
Drug Deliv Transl Res; 2013 Aug; 3(4):309-17. PubMed ID: 23864999
[TBL] [Abstract][Full Text] [Related]
2. A facile approach for synthesis of nano-CeO
Gao Y; Chen X; Liu H
J Photochem Photobiol B; 2018 Oct; 187():184-189. PubMed ID: 30173122
[TBL] [Abstract][Full Text] [Related]
3. Anti-edema action of thyroid hormone in MCAO model of ischemic brain stroke: Possible association with AQP4 modulation.
Sadana P; Coughlin L; Burke J; Woods R; Mdzinarishvili A
J Neurol Sci; 2015 Jul; 354(1-2):37-45. PubMed ID: 25963308
[TBL] [Abstract][Full Text] [Related]
4. Intracisternal administration of tanshinone IIA-loaded nanoparticles leads to reduced tissue injury and functional deficits in a porcine model of ischemic stroke.
Waters ES; Kaiser EE; Yang X; Fagan MM; Scheulin KM; Jeon JH; Shin SK; Kinder HA; Kumar A; Platt SR; Duberstein KJ; Park HJ; Xie J; West FD
IBRO Neurosci Rep; 2021 Jun; 10():18-30. PubMed ID: 33842909
[TBL] [Abstract][Full Text] [Related]
5. Development of Triiodothyronine Polymeric Nanoparticles for Targeted Delivery in the Cardioprotection against Ischemic Insult.
Karakus OO; Darwish NHE; Sudha T; Salaheldin TA; Fujioka K; Dickinson PCT; Weil B; Mousa SA
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829942
[TBL] [Abstract][Full Text] [Related]
6. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
Chen YC; Hsieh WY; Lee WF; Zeng DT
J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in nanomedicines for the treatment of ischemic stroke.
Li C; Sun T; Jiang C
Acta Pharm Sin B; 2021 Jul; 11(7):1767-1788. PubMed ID: 34386320
[TBL] [Abstract][Full Text] [Related]
8. Distribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration.
Miyazawa T; Nakagawa K; Harigae T; Onuma R; Kimura F; Fujii T; Miyazawa T
Int J Nanomedicine; 2015; 10():7223-30. PubMed ID: 26664113
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of astrocyte fatty acid oxidation by thyroid hormone is protective against ischemic stroke-induced damage.
Sayre NL; Sifuentes M; Holstein D; Cheng SY; Zhu X; Lechleiter JD
J Cereb Blood Flow Metab; 2017 Feb; 37(2):514-527. PubMed ID: 26873887
[TBL] [Abstract][Full Text] [Related]
10. Ischemic preconditioning provides long-lasting neuroprotection against ischemic stroke: The role of Nrf2.
Yang T; Sun Y; Li Q; Li S; Shi Y; Leak RK; Chen J; Zhang F
Exp Neurol; 2020 Mar; 325():113142. PubMed ID: 31812555
[TBL] [Abstract][Full Text] [Related]
11. Polyhydroxylated fullerene nanoparticles attenuate brain infarction and oxidative stress in rat model of ischemic stroke.
Vani JR; Mohammadi MT; Foroshani MS; Jafari M
EXCLI J; 2016; 15():378-90. PubMed ID: 27540350
[TBL] [Abstract][Full Text] [Related]
12. Improvement of memory and learning by intracerebroventricular microinjection of T3 in rat model of ischemic brain stroke mediated by upregulation of BDNF and GDNF in CA1 hippocampal region.
Mokhtari T; Akbari M; Malek F; Kashani IR; Rastegar T; Noorbakhsh F; Ghazi-Khansari M; Attari F; Hassanzadeh G
Daru; 2017 Feb; 25(1):4. PubMed ID: 28202057
[TBL] [Abstract][Full Text] [Related]
13. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles.
Kim BS; Kim CS; Lee KM
Arch Pharm Res; 2008 Aug; 31(8):1050-4. PubMed ID: 18787796
[TBL] [Abstract][Full Text] [Related]
14. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.
Avgoustakis K
Curr Drug Deliv; 2004 Oct; 1(4):321-33. PubMed ID: 16305394
[TBL] [Abstract][Full Text] [Related]
15. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V
Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667
[TBL] [Abstract][Full Text] [Related]
16. The application of nanoparticles for neuroprotection in acute ischemic stroke.
Chen L; Gao X
Ther Deliv; 2017 Oct; 8(10):915-928. PubMed ID: 28944741
[TBL] [Abstract][Full Text] [Related]
17. Triiodothyronine modulates neuronal plasticity mechanisms to enhance functional outcome after stroke.
Talhada D; Feiteiro J; Costa AR; Talhada T; Cairrão E; Wieloch T; Englund E; Santos CR; Gonçalves I; Ruscher K
Acta Neuropathol Commun; 2019 Dec; 7(1):216. PubMed ID: 31864415
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells with modafinil (gold nanoparticles) significantly improves neurological deficits in rats after middle cerebral artery occlusion.
Nazarian S; Abdolmaleki Z; Torfeh A; Shirazi Beheshtiha SH
Exp Brain Res; 2020 Nov; 238(11):2589-2601. PubMed ID: 32886135
[TBL] [Abstract][Full Text] [Related]
19. Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.
Gelperina S; Maksimenko O; Khalansky A; Vanchugova L; Shipulo E; Abbasova K; Berdiev R; Wohlfart S; Chepurnova N; Kreuter J
Eur J Pharm Biopharm; 2010 Feb; 74(2):157-63. PubMed ID: 19755158
[TBL] [Abstract][Full Text] [Related]
20. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
